Ongoing HTAs by AVALIA-T in Spain in November 2024

In November 2024, the Galician Agency for Health Technology Assessment (AVALIA-T) is working on several HTAs, including in cardiovascular, e-health, ICU/OR, in-vitro diagnostics, neurology and neurosurgery, neuromodulation, orthopedics, pulmonary and airways, radiotherapy, surgical procedures, and some other fields. These projects are being elaborated within the annual work plan of the Spanish Network of HTA Agencies (RedETS), financed by the Ministry of Health. Some examples can be found below:

• Safety and clinical effectiveness of cryoanalgesia in pediatric patients after "pectus excavatum" surgery;
• Peripherally inserted central catheter with reservoir (PICC-port) versus thoracic reservoir with central catheter (Port-a-Cath) in patients undergoing chemotherapy;
• Utility of liquid biopsy in the management of colorectal cancer in I-IV stages;
• Adaptive deep brain stimulation in Parkinson's disease;
• Lattice radiotherapy in the curative or palliative treatment of deep, high-volume tumors and metastatic or irresectable disease;
• Diagnostic and clinical utility of impulse oscillometry for use in patients with difficulty performing spirometry.

See the full details in Spanish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.